Document Detail

KL-6 as a serologic indicator of Pneumocystis carinii pneumonia in immunocompromised hosts.
MedLine Citation:
PMID:  9617869     Owner:  NLM     Status:  MEDLINE    
KL-6, a serum marker for interstitial pneumonitis, was evaluated in patients with Pneumocystis carinii pneumonia (PCP). Patient 1 was a 56-year-old woman with rheumatoid arthritis treated with immunosuppressive drugs and corticosteroids. Patient 2 was a 59-year-old man with a glioblastoma who received anti-cancer drugs and corticosteroids. In both patients, serum KL-6 showed an abnormally high level due to the complication of PCP, and it decreased following successful treatment. These results indicate that PCP is one of the diseases in which serum KL-6 increases.
H Hamada; N Kohno; A Yokoyama; Y Hirasawa; K Hiwada; M Sakatani; E Ueda
Related Documents :
2804889 - Evaluation of serum levels of soluble interleukin-2 receptor in patients with chronic l...
22382349 - Clinical correlates of cenp-a and cenp-b antibodies in a large cohort of patients with ...
2310279 - Hypoalbuminemia in patients with multiple myeloma.
10618619 - Tumor markers at the time of recurrence in patients with germ cell tumors.
12486319 - Serum soluble interleukin-2 receptor in eosinophilia.
14611909 - Serum levels of chemokines correlate with disease activity in patients with retinal vas...
15193449 - Deletion of 5q31 and 7q31 in patients with stable melphalan treated multiple myeloma.
19954389 - Hyperhomocysteinemia in patients with stasis dermatitis and ulcer: a novel finding with...
6406579 - Influence of posture on gas exchange in artificially ventilated patients with focal lun...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Internal medicine (Tokyo, Japan)     Volume:  37     ISSN:  0918-2918     ISO Abbreviation:  Intern. Med.     Publication Date:  1998 Mar 
Date Detail:
Created Date:  1998-07-27     Completed Date:  1998-07-27     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9204241     Medline TA:  Intern Med     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  307-10     Citation Subset:  IM    
Department of Internal Medicine, National Kinki-Chuo Hospital for Chest Diseases, Osaka.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, Neoplasm
Arthritis, Rheumatoid / complications,  drug therapy
Biological Markers / blood*
Brain Neoplasms / complications,  drug therapy
Follow-Up Studies
Glioblastoma / complications,  drug therapy
Immunocompromised Host*
Immunosuppressive Agents / therapeutic use
Middle Aged
Mucins / blood*
Peptide Fragments / blood*
Pneumonia, Pneumocystis / blood*,  complications,  pathology
Procollagen / blood*
Reg. No./Substance:
0/Antigens; 0/Antigens, Neoplasm; 0/Biological Markers; 0/Glycoproteins; 0/Immunosuppressive Agents; 0/MUC1 protein, human; 0/Mucin-1; 0/Mucins; 0/Peptide Fragments; 0/Procollagen; 0/procollagen Type III-N-terminal peptide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sarcoid reactions scattered in the tumor-bearing lung parenchyma and regional lymph nodes associated...
Next Document:  Non-Hodgkin's lymphoma involving bilateral breasts.